Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Multiple Sclerosis

Free Subscription 01.07.2019 2 Arch Phys Med Rehabil 2 BMC Neurol 1 Int J Neurosci 2 J Neurol Sci 3 Mult Scler 1 Rev Neurol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Arch Phys Med Rehabil

1. KRAUSE JS, Dismuke-Greer CE, Reed KS, Rumrill P, et al
   Employment and job benefits among those with spinal cord dysfunction: A comparison of people with spinal cord injury and multiple sclerosis.
   Arch Phys Med Rehabil. 2019 Jun 24. pii: S0003-9993(19)30400.
   PubMed     Text format     Abstract available
   
   
2. PLOW M, Finlayson M, Liu J, Motl RW, et al
   Randomized controlled trial of a telephone-delivered physical activity and fatigue self-management interventions in adults with multiple sclerosis.
   Arch Phys Med Rehabil. 2019 Jun 20. pii: S0003-9993(19)30397.
   PubMed     Text format     Abstract available
   
   

   
   BMC Neurol

3. FINLAYSON M, Akbar N, Turpin K, Smyth P, et al
   A multi-site, randomized controlled trial of MS INFoRm, a fatigue self-management website for persons with multiple sclerosis: rationale and study protocol.
   BMC Neurol. 2019;19:142.
   PubMed     Text format     Abstract available
   
   
4. HONG Y, Tang HR, Ma M, Chen N, et al
   Multiple sclerosis and stroke: a systematic review and meta-analysis.
   BMC Neurol. 2019;19:139.
   PubMed     Text format     Abstract available
   
   

   
   Int J Neurosci

5. HALICIOGLU S, Turkoglu SA
   Role of developmental venous anomalies in etiopathogenesis of demyelinating diseases.
   Int J Neurosci. 2019;129:245-251.
   PubMed     Text format     Abstract available
   
   

   
   J Neurol Sci

6. MASUDA H, Mori M, Hirano S, Kojima K, et al
   Relapse numbers and earlier intervention by disease modifying drugs are related with progression of less brain atrophy in patients with multiple sclerosis.
   J Neurol Sci. 2019;403:78-84.
   PubMed     Text format     Abstract available
   
   
7. SEDEEQ MS, El-Nahrery EMA, Shalaby N, Hussein M, et al
   Micro-RNA-96 and interleukin-10 are independent biomarkers for multiple sclerosis activity.
   J Neurol Sci. 2019;403:92-96.
   PubMed     Text format     Abstract available
   
   

   
   Mult Scler

8. DE LOTT LB, Zerafa S, Shedden K, Dunietz GL, et al
   Multiple sclerosis relapse risk in the postoperative period: Effects of invasive surgery and anesthesia.
   Mult Scler. 2019 Jun 25:1352458519860304. doi: 10.1177/1352458519860304.
   PubMed     Text format     Abstract available
   
   
9. INEICHEN BV, Moridi T, Granberg T, Piehl F, et al
   Rituximab treatment for multiple sclerosis.
   Mult Scler. 2019 Jun 25:1352458519858604. doi: 10.1177/1352458519858604.
   PubMed     Text format     Abstract available
   
   
10. LEAVITT VM, Brandstadter R, Fabian M, Katz Sand I, et al
    Dissociable cognitive patterns related to depression and anxiety in multiple sclerosis.
    Mult Scler. 2019 Jun 24:1352458519860319. doi: 10.1177/1352458519860319.
    PubMed     Text format     Abstract available
    
    

    
    Rev Neurol

11. PEREZ-CARMONA N, Fernandez-Jover E, Sempere AP
    [Epidemiology of multiple sclerosis in Spain].
    Rev Neurol. 2019;69:32-38.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: